Ko DT - Search Results

1

Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Ozaki AF, Choi AS, Le QT, Ko DT, Han JK, Park SS, Jackevicius CA. Ozaki AF, et al. Among authors: ko dt. Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e005969. doi: 10.1161/CIRCOUTCOMES.119.005969. Epub 2020 Mar 9. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32148102

2

Use of ezetimibe in the United States and Canada.

Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM. Jackevicius CA, et al. Among authors: ko dt. N Engl J Med. 2008 Apr 24;358(17):1819-28. doi: 10.1056/NEJMsa0801461. Epub 2008 Mar 30. N Engl J Med. 2008. PMID: 18375999 Free article.

3

National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004.

Tu JV, Nardi L, Fang J, Liu J, Khalid L, Johansen H; Canadian Cardiovascular Outcomes Research Team. Tu JV, et al. CMAJ. 2009 Jun 23;180(13):E118-25. doi: 10.1503/cmaj.081197. CMAJ. 2009. PMID: 19546444 Free PMC article.

4

Long-term trends in use of and expenditures for cardiovascular medications in Canada.

Jackevicius CA, Cox JL, Carreon D, Tu JV, Rinfret S, So D, Johansen H, Kalavrouziotis D, Demers V, Humphries K, Pilote L; Canadian Cardiovascular Outcomes Research Team. Jackevicius CA, et al. CMAJ. 2009 Jul 7;181(1-2):E19-28. doi: 10.1503/cmaj.081913. CMAJ. 2009. PMID: 19581604 Free PMC article.

5

Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors.

Lee DS, Chiu M, Manuel DG, Tu K, Wang X, Austin PC, Mattern MY, Mitiku TF, Svenson LW, Putnam W, Flanagan WM, Tu JV; Canadian Cardiovascular Outcomes Research Team. Lee DS, et al. CMAJ. 2009 Aug 4;181(3-4):E55-66. doi: 10.1503/cmaj.081629. Epub 2009 Jul 20. CMAJ. 2009. PMID: 19620271 Free PMC article.

6

Determinants of cardiac catheterization use in older Medicare patients with acute myocardial infarction.

Ko DT, Ross JS, Wang Y, Krumholz HM. Ko DT, et al. Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):54-62. doi: 10.1161/CIRCOUTCOMES.109.858456. Epub 2009 Dec 8. Circ Cardiovasc Qual Outcomes. 2010. PMID: 20123672 Free PMC article.

7

Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years.

Ko DT, Yun L, Wijeysundera HC, Jackevicius CA, Rao SV, Austin PC, Marquis JF, Tu JV. Ko DT, et al. Circ Cardiovasc Interv. 2010 Apr;3(2):140-7. doi: 10.1161/CIRCINTERVENTIONS.109.928721. Epub 2010 Mar 23. Circ Cardiovasc Interv. 2010. PMID: 20332382

8

The potential economic impact of restricted access to angiotensin-receptor blockers.

Guertin JR, Jackevicius CA, Cox JL, Humphries K, Pilote L, So DY, Tu JV, Wijeysundera H, Rinfret S; Canadian Cardiovascular Outcomes Research Team. Guertin JR, et al. CMAJ. 2011 Feb 22;183(3):E180-6. doi: 10.1503/cmaj.100787. Epub 2011 Jan 24. CMAJ. 2011. PMID: 21262939 Free PMC article.

9

Use of fibrates in the United States and Canada.

Jackevicius CA, Tu JV, Ross JS, Ko DT, Carreon D, Krumholz HM. Jackevicius CA, et al. Among authors: ko dt. JAMA. 2011 Mar 23;305(12):1217-24. doi: 10.1001/jama.2011.353. JAMA. 2011. PMID: 21427374 Free PMC article.

10

Effectiveness of preprocedural statin therapy on clinical outcomes for patients with stable coronary artery disease after percutaneous coronary interventions.

Ko DT, Wijeysundera HC, Yun L, Austin PC, Cantor WJ, Tu JV. Ko DT, et al. Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):459-66. doi: 10.1161/CIRCOUTCOMES.111.960740. Epub 2011 Jun 28. Circ Cardiovasc Qual Outcomes. 2011. PMID: 21712520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

344 results

Search Page